> Health

Asco Speaker Center Login

Scholar Salt Lake City, UT

Find top links about Asco Speaker Center Login along with social links, FAQs, and more. If you are still unable to resolve the login problem, read the troubleshooting steps or report your issue.

Mar 23, 22 (Updated: Oct 27, 22)

What problem are you having with asco.org?
Select an option that best describe your problem. You can also post issue detail or ask any query to get answer from site admin or community.
Post Issue Detail
No status report submitted in last 7 days.
1. Asco.org
Explainer London 2 years ago

User login · Connect with Us · Footer 1 · Footer 2 · Footer 3 · Your Privacy.

Social Handles

Page Status Information

Checked At HTTP Status Code Connect Time (ms) Result
2024-05-02 22:15:36 403 254 Temporarily Down
2024-04-30 19:02:59 403 62 Temporarily Down
2024-04-24 15:18:45 403 254 Temporarily Down
4
1
2. Confex.com
Legendary Denmark 2 years ago

https://asco.confex.com/asco/2019/gateway.cgi

https://asco.confex.com/asco/2019/gateway.cgi
6
1
3. Ascopubs.org
Populist New York, United States 2 years ago

Author Center | Journal of Clinical Oncology

https://ascopubs.org/jco/authors/author-center

Enter words / phrases / DOI / ISBN / authors / keywords / etc. Search in: Search This Journal, Search ASCO Journals.

5
1
Informed Orange, California United States 2 years ago

JCO PO is published by the American Society of Clinical Oncology (ASCO). ... are unable to distinguish from those written by native English speakers.

4
1
4. Smapply.org
Organizer Green Bay, WI 2 years ago

ASCO Joint Sessions - Application Portal

https://asco.smapply.org/prog/asco_joint_sessions

The session includes speakers from both ASCO and the requesting organization. Both organizations mutually agree upon topics and speakers.

2
1
5. Lww.com
Organizer Sofia, Bulgaria 2 years ago

What to Expect From the Virtual 2021 ASCO Annual Meeting

https://journals.lww.com/oncology-times/fulltext/2021/05200/what_to_ex...

Participants can also connect with presenters during the ... Browse the ASCO Career Center for open positions organized by location, ...

5
0
6. Horizoncme.com
Outspoken Australia 2 years ago

Upcoming ASCO Direct™ Highlights - Horizon CME

https://horizoncme.com/asco-direct-highlights/conferences-live

Upcoming ASCO Direct™ Highlights ... Get the latest medical education news from APP Oncology Summit about online courses, speakers and conferences.

5
1
7. Upmc.com
Guru 1 year ago

2021 ASCO Review - UPMC - Center for Continuing ...

https://cce.upmc.com/ASCO-review-2021

To provide a comprehensive overview of topics of greatest importance as presented at the 2021 ASCO Annual Meeting.

3
0
8. Advocateaurorahealth.org
Teacher 1 year ago

14th Annual Highlights of ASCO | CME Advocate Aurora Health

https://cme.advocateaurorahealth.org/content/14th-annual-highlights-as...

This program is designed for physicians, PAs, nurse practitioners, registered nurses, medical staff and pharmacists in Wisconsin and neighboring states ...

7
1
9. Accc-cancer.org
Informed Canada 1 year ago

ASCO [Virtual] Direct™ Highlights - Phoenix - Association of ...

https://www.accc-cancer.org/home/attend/event-template/2021/07/10/defa...
0
1
10. Eventsinamerica.com
Refiner Bogota, Colombia 1 year ago

2021 ASCO Annual Meeting - American Society Of Clinical ...

https://eventsinamerica.com/events/2021-asco-annual-meeting-american-s...

\r\n About ASCO: \r\n Founded in 1964, the American Society of Clinical Oncology is the world\'s leading ... Keynote speaker - December 1969 - December 1969.

5
0
11. Astro.org
Announcer Hyderabad, Telangana, India 1 year ago

2021 ASTRO Annual Meeting - Meeting and Education

https://www.astro.org/Meetings-and-Education/Micro-Sites/2021/Annual-M...

Join us October 24-27 in Chicago for ASTRO's in-person meeting. Learn more.

2
0
12. Jspargo.com
Teacher 1 year ago

Seattle Cancer Care Alliance - 2021 ASCO Annual Meeting

https://events.jspargo.com/asco21/public/eBooth.aspx?IndexInList=717&F...

SCCA is the only NCI-designated cancer center in Washington state. We have nine treatment centers in the Seattle ... 3 Featured ASCO Speakers (May 27, 2021).

1
1
13. Binayfoundation.org
Disciplined Burnaby, BC 1 year ago

ASCO Direct™ Highlight: 2021 Official Annual Meeting Review

https://education.binayfoundation.org/asco-review-2021

A number of potentially practice-changing abstracts were presented during the 2021 ASCO Annual Meeting in June, 2021 (ASCO2021). Expert faculty will place ...

0
0
14. Sgo.org
Editor Shanghai, China 1 year ago

Annual Meeting on Women's Cancer | SGO - Society of ...

https://www.sgo.org/events/annual-meeting/

The Annual Meeting on Women's Cancer is a comprehensive forum for the subspecialty of gynecologic oncology. Whether you're a physician, surgeon, researcher, ...

1
1
15. Cancer.net
Organizer Cape Town, South Africa 1 year ago

2021 ASCO Annual Meeting Research Round Up - Cancer.Net

https://www.cancer.net/blog/2021-06/2021-asco-annual-meeting-research-...

Dr. Gilligan is a medical oncologist at the Cleveland Clinic Taussig ... Disclosure information for this webinar's speakers can be found in ...

7
0
16. Soc-neuro-onc.org
Announcer Bangalore, Karnataka, India 1 year ago

Society for Neuro-Oncology

https://www.soc-neuro-onc.org/

Save the Date for the 2022 Second Annual Conference • Toronto, Canada • August 12-13, 2022 • Co-sponsored by SNO and ASCO ...

3
0
17. Ascopost.com
Announcer Luxembourg 1 year ago

2021 ASCO Annual Meeting: Next-Generation Oncology ...

https://ascopost.com/issues/august-10-2021/2021-asco-annual-meeting-ne...

Jhanelle Elaine Gray, MD, of Moffitt Cancer Center, chaired the session ... and has served as a speaker for AstraZeneca, Roche, and BMS.

3
0
18. Thescrubb.com
Editor Cumming, GA, USA 1 year ago

What to Expect at ASCO 2021 Annual Meeting - TheScrubb

https://thescrubb.com/what-to-expect-at-asco-21/

NCI Director's Address: Norman E. Sharpless, MD from the National Cancer Institute at the National Institutes of Health;; Guest Speaker's ...

2
1
19. Esmo.org
Editor Quebec City, Canada 1 year ago

ESMO Congress 2021

https://www.esmo.org/meetings/past-meetings/esmo-congress-2021

The ASCO Post @ASCOPost. Filippo Pietrantonio, MD, and Federica Morano, MD, on Colorectal Cancer and the MAYA Trial Strategy: Temozolomide, Ipilimumab, ...

5
1
20. Doximity.com
Guru United Kingdom 1 year ago

Trying to Focus on ASCO In the Middle of a Crisis - Op-Med

https://opmed.doximity.com/articles/trying-to-focus-on-asco-in-the-mid...

While we all were extremely sad that this year's ASCO had been ... to previous ASCO conferences where I was able to give the speaker my ...

0
0
21. Medscape.com
Curious UT 1 year ago

'Chemoboy' Takes Center Stage at ASCO Meeting - Medscape

https://www.medscape.com/viewarticle/913785

This theme of what is important to patients was also highlighted at the opening ceremony by the guest speaker, Atul Gawande, MD, a surgeon at ...

2
0
22. Eventsair.com
Populist Pune, Maharashtra, India 1 year ago

2019 ASCO Direct Highlights - EventsAIR

https://mayscc.eventsair.com/2019-asco-direct-highlights/

UT Health San Antonio ASCO Direct™ Highlights 2019 Official Annual ... speakers. Sukeshi Patel Arora, MD. UT Health San Antonio MD Anderson Cancer Center.

5
0
23. Nursingcenter.com
Announcer Denmark 1 year ago

What to Expect From the Virtual 2021 AsCO Annual Meeting

https://www.nursingcenter.com/wkhlrp/Handlers/articleContent.pdf?key=p...

The 2021 ASCO Annual Meeting, which will be held online ... Pierce, MD, as well as guest speakers who are experts in health policy.

4
0
24. Upmcphysicianresources.com
Reviewer 1 year ago

UPMC at 2018 American Society of Clinical Oncology Annual ...

https://www.upmcphysicianresources.com/news/upmc-physicians-and-resear...

The 2018 ASCO Annual Meeting will be held June 1-5, ... Texas MD Anderson Cancer Center Thomas James ... Robert Noll, PhD - Speaker

6
0
25. Uab.edu
Populist Hyderabad, Telangana, India 1 year ago

Exercise, Her2+ are topics UAB cancer specialists will cover at ...

https://www.uab.edu/news/health/item/2467-exercise-her2-are-topics-uab...

UAB faculty will give 25 presentations at ASCO scientific meeting; ... An invited speaker for the educational session, Cancer Prevention for ...

3
1

If you know a webpage link that work for the reported issue. Consider sharing with the community by adding in the above list. After verification of provided information, it would be get listed on this web page.

Frequently Asked Questions

Is ASCO a reliable source?

The Journal of Clinical Oncology is the preeminent, peer-reviewed medical journal on clinical cancer research.

Who can be a member of ASCO?

Physicians during the first three years after completion of an approved oncology subspecialty training program and who qualify for Full membership. Annual Dues: $300. Physicians eligible for Full membership who reside in a country with a low per-capita income, as defined by the World Bank list of economies.

Who funds ASCO?

Conquer Cancer®, the ASCO Foundation, is a nonprofit organization created in 1999 by ASCO to seek dramatic advances in the diagnosis, prevention, treatment, and cure of all types of cancer. The ASCO Annual Meeting is funded through Conquer Cancer®, the ASCO Foundation, by these generous donors.

What does ASCO stand for?

American Society of Clinical Oncology
Formation 1964
Membership Nearly 45,000
Official language English
President Lori J. Pierce
Website asco.org

Recent Tweets By asco

Lamp
@ASCO A thought-provoking and timely keynote. Thanks for joining us at #GI23! #HealthAI #OncTwitter https://t.co/tbKe721h3M
2023-01-25 07:34:49
Lamp
@ASCO “In May 2022, ASCO released new recs supporting exercise during active cancer tx... They concluded that cancer care providers should recommend that people undergoing cancer tx – either chemo or radiation therapy – take part in regular aerobic and strength-training exercises...” https://t.co/g158UYOOBl
2023-01-24 11:54:16
Lamp
@ASCO #ASCOPlenarySeries: INTRIGUE #ctDNA analysis uncovers distinct molecular subgroups of GIST with enhanced response to ripretinib and sunitinib: https://t.co/oArPXE1mSY @breelynwilkyMD @SalemGIOncDoc @seppobauer @ChristianRolfo #gi23 #sarcoma #ASCODailyNews
2023-01-24 09:12:01
Lamp
@ASCO Don't miss the #ASCOPlenarySeries TODAY @ 3 PM ET! The session will highlight the use of #ctDNA in predicting tx efficacy in #GIST Presenter: @seppobauer Panelists: @SalemGIOncDoc @breelynwilkyMD @ChristianRolfo Details ➡️ https://t.co/cTVUuSw5T3 #gi23 #sarcoma @OncoAlert https://t.co/hVj03GoHV2
2023-01-24 07:30:03
Lamp
@ASCO ‼️ January #ASCOPlenarySeries session to highlight the role of #ctDNA in predicting tx efficacy in #GIST, other tumors 📅 Live presentation 1/24 @ 3 PM ET  Panelists: @SalemGIOncDoc @seppobauer @breelynwilkyMD @ChristianRolfo  Abstract: https://t.co/mbyk3SjpIt @OncoAlert #GI23 https://t.co/yDjpoNCyWZ
2023-01-23 11:05:03
Lamp
@ASCO We’re accepting comments on our draft guideline update re: systemic therapy for #sclc. Submit feedback by January 31. https://t.co/6wn3v4wjwV #lcsm https://t.co/MB6LseRZ5q
2023-01-23 09:10:03
Lamp
@ASCO A recording of @McNeill_Dr's #GI23 keynote lecuture is now available: Equitable Solutions for Reducing Excess Mortality in Minority Populations Watch here ➡️ https://t.co/R5biBYGOgN #healthequity #onctwitter #medtwitter https://t.co/nwoLnmbPcx
2023-01-22 12:45:03
Lamp
@ASCO As immunotherapy has limited benefit in #gastriccancer, Drs. Zoulikha M. Zaïr and Ian Chau discuss how improving precision medicine will require a holistic approach: https://t.co/OVsaQzUmYH #GI23 #ASCODailyNews #gicsm
2023-01-22 06:21:01
Lamp
@ASCO For #ASCODailyNews, @drjunaidarsh and Dr. Nikolaos Trikalinos review the challenging history, current state, and hopeful future of #neuroendocrine neoplasm research and treatment efforts: https://t.co/8Woyb84x2G #GI23 #gicsm
2023-01-22 04:29:33
Lamp
@ASCO As the final day of #GI23 comes to a close, visit the #ASCODailyNews hub of Symposium coverage and catch up on all the coverage you may have missed: https://t.co/vgOl4YQg3F
2023-01-21 11:02:01
Lamp
@ASCO @vinzumab @KUcancercenter Thanks for joining us! 🎉 #GI23
2023-01-21 10:28:58
Lamp
@ASCO New research from #GI23: Levels of #cfDNA do not impact #ctDNA detection in patients with #CRC: https://t.co/XwoVuwZ8nP #ASCODailyNews #crcsm
2023-01-21 08:17:01
Lamp
@ASCO More practice-changing research from #GI23: SUNLIGHT study finds adding bev to trifluridine/tipiracil in the treatment of refractory #mCRC improved median OS compared w/ trifluridine/tipiracil alone: https://t.co/40KgLRtLCd #ASCODailyNews @TaberneroJosep @vallhebron #crcsm
2023-01-21 08:12:01
Lamp
@ASCO CRC survivor & patient advocate @ARosen380 shares her #GI23 takeaways: 🎯 Innovations in targeted tx 🗣️ Conversations about health disparities, patient care and #survivorship 🔍 Growing attention on early-age onset CRC #crcsm #gicsm https://t.co/UJVGuah5fb
2023-01-21 07:43:24
Lamp
@ASCO Starting now! #GI23 keynote with @McNeill_Dr: Equitable Solutions for Reducing Excess Mortality in Minority Populations Read more in #ASCODailyNews ➡️ https://t.co/sx5pSL6bKz #healthequity #onctwitter https://t.co/oQsIs5e4jS
2023-01-21 05:51:24
Lamp
@ASCO cc: @KoheiShitara #GI23
2023-01-21 04:45:42
Lamp
@ASCO Just-presented PARADIGM analysis from #GI23: Hyperselection using #ctDNA instead of tumor sidedness may better determine if a patient should receive first-line panitumumab or bevacizumab: https://t.co/aPEICNf1oR #ASCODailyNews #gicsm
2023-01-21 04:28:33
Lamp
@ASCO #GI23 Debate 🤔 Is first-line EGFR antibody an essential treatment for a fit patient w/ unresectable metastatic RAS wild-type sigmoid colon adenocarcinoma? Join us today @ 3:15 PM PT for Refinement of mCRC Management to discuss!
2023-01-21 03:56:49
Lamp
@ASCO What’s your fondest ASCO GI memory? Thanks to long-time attendee @ShaalanBeg for compiling these memories from the past 20 years 🥳 #GI23 https://t.co/JwI0l3wajP
2023-01-21 02:49:56
Lamp
@ASCO #GI23 Debate 🤔 Germline Genetic Testing in Colorectal Cancer: Should It Be Performed Universally? Join us tomorrow (Saturday) @ 7:00 AM PT for the Breakout Session to discuss!
2023-01-21 02:22:59
Lamp
@ASCO ASCO CMO Dr. @jrgralow shares a #GI23 welcome from San Francisco. 🌉 We’re looking forward to a terrific few days of GI #CancerResearch rooted in this year’s theme of Applying Innovation, Transforming Care, and Advancing Equity. https://t.co/fY7f6OGhgC
2023-01-20 12:29:45
Lamp
@ASCO @ARosen380 Thank you for joining us and for your invaluable perspective & advocacy! #GI23
2023-01-20 07:51:42
Lamp
@ASCO Happening now! #GI23 keynote with @mattlungrenMD: AI in Oncology More in #ASCODailyNews ➡️ https://t.co/4igyydNJSN #HealthAI #OncTwitter https://t.co/H7Ki8h5Mnw
2023-01-20 07:35:04
Lamp
@ASCO #GI23 Grab a mochi donut 🍩 & boba tea 🧋 and learn about the ASCO Breakthrough meeting happening in Japan & online this August. #ASCOBT23 Co-hosts: @JSMO_official, JSCO Learn more at https://t.co/tMeRAJTiuF https://t.co/TAos279eJV
2023-01-20 06:07:57
Lamp
@ASCO @HPolymenis @manjuggm Nonmember Pt Advocates interested in registering for free online access can submit a CV or bio-sketch via email to [email protected]. ASCO Member Pt Advocates will automatically receive free online rate when using the registration website. More: https://t.co/kdypG9rDr9
2023-01-20 04:56:40
Lamp
@ASCO #GI23 Debate 🤔 Liver Transplantation for Intrahepatic CCA and Metastatic Colorectal Cancer: Are We There Yet? Join us tomorrow (Friday) @ 7 AM PT for Breakout Session: Pushing the Envelope in Transplant Oncology for more!
2023-01-20 02:36:04
Lamp
@ASCO Practice-changing research from #GI23: Zolbetuximab + mFOLFOX6 meets primary endpoint in SPOTLIGHT trial, improves PFS, OS in pts w/ CLDN18.2+, HER2-negative, locally advanced unresectable or metastatic gastric or GEJ cancer: https://t.co/5N2pBLFKFF #ASCODailyNews #gicsm #esocsm
2023-01-19 10:43:00
Lamp
@ASCO Final INTEGRATE-IIa results from #GI23: Regorafenib improves survival in refractory advanced GEJ. 12-month survival rate was 19% with regorafenib and 6% for placebo. #ASCODailyNews has more: https://t.co/jBWCcTdq8p #gicsm
2023-01-19 08:12:01
Lamp
@ASCO Join us for lunch, posters, exhibits and cake 🎂 to celebrate 20 years of ASCO GI! #GI23 https://t.co/DdjEwJsRO5
2023-01-19 07:53:08
Lamp
@ASCO Day 1 of #GI23 is underway in San Francisco 🌉 & online! We’re thrilled to be celebrating 20 years 🎉 What year was your first ASCO GI? https://t.co/PhyHMXW3sm
2023-01-19 05:47:42
Lamp
@ASCO Research from #GI23 is now available! #ASCODailyNews is covering just-released abstracts from the upcoming Symposium, read all articles now: https://t.co/jFzI1z9IVe #gicsm #OncTwitter
2023-01-18 12:00:02
Lamp
@ASCO Oncologists from @DukeMedSchool discuss how the shift toward TNT for LARC treatment has improved outcomes, but opportunities remain to further improve disease control & augment availability of NOM options: https://t.co/uL4749R7UM #GI23 #ASCODailyNews @AcklinScarlett
2023-01-18 11:17:01
Lamp
@ASCO A new study from #GI23 finds that areas in the U.S. with high levels of food insecurity also have greater rates of GI cancer mortality, reinforcing the importance of adequate #nutrition during treatment. #ASCODailyNews has more: https://t.co/dtmJvQOzPr #gicsm
2023-01-18 09:31:06
Lamp
@ASCO #ASCO23 abstract submissions are open!  Submit your cutting-edge and clinically relevant research to the world’s largest clinical cancer research meeting ➡️ https://t.co/nesEYLodNZ https://t.co/oNclCCHrdk
2023-01-18 08:15:16
Lamp
@ASCO Exciting to see our affiliates engage their state lawmakers. Thank you to Dr. Yogesh Jethava for testifying in support of establishing a drug repository program in Indiana! @OSSatACCC #ASCOAdvocacy https://t.co/IrgdwfG27W
2023-01-18 07:07:59
Lamp
@ASCO In his upcoming #GI23 keynote lecture, @mattlungrenMD will present the latest developments, current challenges, & auspicious future of #AI in oncology and health care. #ASCODailyNews has more: https://t.co/8e7GAVyREV #healthdata
2023-01-18 01:15:01
Lamp
@ASCO The #GI23 abstracts are now available ‼️ Stay updated on the latest innovative science in GI cancers & browse the meeting program ➡️ https://t.co/CzoE7FH9dQ #gicsm @AmerGastroAssn @ASTRO_org @SocSurgOnc https://t.co/PyXum7Gpqh
2023-01-17 10:30:03
Lamp
@ASCO 🎉 Announcing the #GI23 Featured Voices! Follow along for expert insights & join the discussion leading up to and during the Symposium. ⬇️ @TimothyJBrownMD @CathyEngMD @pashtoonkasi @PamelaKunzMD @realbowtiedoc @mpalta1098 @FlavioRochaMD @ARosen380 @rachnatshroff https://t.co/9D1UR3DCvk
2023-01-17 07:00:05
Lamp
@ASCO Patients with #SCLC that metastasize to the brain may benefit from stereotactic radiosurgery. KOLs break down what is known regarding patient selection for #ASCODailyNews: https://t.co/u9XENqboh8 @jainprantesh #lcsm
2023-01-16 10:32:01
Lamp
@ASCO #ASCODailyNews profiles #GI23 keynote speaker @McNeill_Dr of @MDAndersonNews, who encourages working together to eliminate health disparities and reduce excess mortality in minority populations: https://t.co/5YJjAR2AUr #healthequity
2023-01-16 05:04:55
Lamp
@ASCO Ki-67 is an established biomarker in early-stage #BreastCancer in the neoadjuvant setting, but its role in adjuvant therapy is controversial. Here’s why: https://t.co/n9PxgA8jmA #ASCODailyNews @Atandondoc #bcsm
2023-01-09 03:14:02
Lamp
@ASCO It's time to plan your #GU23 Symposium experience! Learn how to register, access the content in person or online, attend events, connect with colleagues, and earn CE credit: https://t.co/DIq4evtcbq
2023-01-09 02:55:01
Lamp
@ASCO For #ASCODailyNews, @janakirammurali and Dr. Christine Ye discuss the role of anti-CD38 antibody therapy in induction & maintenance in newly diagnosed #MultipleMyeloma & how to adopt it in clinical practice: https://t.co/Mf3kYx4fGj #mmsm
2023-01-08 02:47:01
Lamp
@ASCO The SOC for HCC has shifted from TKIs to IO-based approaches. @PestanaRC & @ShirajSenMDPhD discuss how interpreting subtle differences in eligibility criteria & patient selection will be critical as the treatment landscape evolves: https://t.co/79p23ZZLAK
2023-01-07 06:45:01
Lamp
@ASCO ‼️ The January #ASCOPlenarySeries session will highlight the role of #ctDNA in predicting treatment efficacy in GIST & other tumors. 📅 Live presentation 1/24 @ 3 PM ET. Details ➡️ https://t.co/FoPnIKXCQj @OncoAlert @SalemGIOncDoc @seppobauer @breelynwilkyMD @ChristianRolfo https://t.co/zmwEfXDMLE
2023-01-06 11:10:02
Lamp
@ASCO Now available: Our first guideline for IO and targeted therapy in advanced gastroesophageal cancer. Learn more in #ASCODailyNews: https://t.co/0bMW1tWIvc #immunoonc #esocsm @mdmanishshah @JCO_ASCO
2023-01-06 09:10:01
Lamp
@ASCO We've endorsed a new College of American Pathologists guideline that could help oncologists identify suitable candidates for #ICI therapy. Find out more via #ASCODailyNews: https://t.co/P2ctFjOii9 @Pathologists #OncTwitter
2023-01-06 09:05:00
Lamp
@ASCO For #ASCODailyNews, @AshaKarippot and @aparna1024 discuss the striking increase of #CRC in people younger than 50 and the need to understand why: https://t.co/pydpGsBWJU #crcsm #gicsm
2023-01-06 05:13:01
Lamp
@ASCO It's the 20-year anniversary of the ASCO GI Cancers Symposium, which means #GI23 will be a celebration of 2 decades of transformative care. #ASCODailyNews has more on what the Symposium will offer: https://t.co/zFfJfxBz0j
2023-01-05 09:58:01
Lamp
@ASCO 🎙️ @fumikochino, @AnnaLeeMDMPH & @ErinGillespieMD discuss a new @JAMANetworkOpen survey of 1,000+ female oncologists on family building, fertility concerns & #GenderEquity on the latest #ASCODailyNews Podcast: https://t.co/r64azZVZLv
2023-01-05 06:52:00
Lamp
@ASCO PBT is a rapidly evolving advanced radiation therapy technique that has the potential to improve treatment outcomes for patients with GI cancers. #ASCODailyNews covers what we know so far: https://t.co/T5NNt3jHP1 #gicsm #radonc
2023-01-05 04:05:00
Lamp
@ASCO 📅 Reminder: Early registration for #GU23 ends January 11! Don't miss your chance to secure the best rates for the leading event for GU cancers ➡️ https://t.co/fqrzz28kO6 @ASTRO_org @UroOnc https://t.co/1Fuk9BFF4T
2023-01-04 11:05:02
Lamp
@ASCO KOLs from @MDAndersonNews shed light on the ongoing challenges that peritoneal metastases pose in #CRC and explore promising targeted therapy and IO treatment approaches: https://t.co/tlgwDTeSaQ @jpshen_md @ColonCancerDoc #GI23 #ASCODailyNews #crcsm
2023-01-04 05:56:00
Lamp
@ASCO It's time to start planning your #GI23 Symposium experience! Find out how to register, access meeting content in person or online, attend events, connect with colleagues, and earn CE credit: https://t.co/bpTyrH94Pt #gicsm #OncTwitter
2023-01-03 12:23:00
Lamp
@ASCO "I began my medical career in Arizona, where I received an early lesson in the importance of cultural sensitivity thanks to members of the Navajo Nation from the Four Corners region," shares @FrankLMeyskens https://t.co/pJHJbgk4eN #ASCOconnection
2023-01-01 01:00:01
Lamp
@ASCO We're committed to supporting a diverse oncology workforce through a robust portfolio of professional development offerings. Learn more: https://t.co/seTVkjtyLh #ASCOconnection #OncTwiter #MedEd
2022-12-30 04:00:01
Lamp
@ASCO "Cancer research relevant to LMICs is a necessity, not a luxury," writes @elbairikhalid19. https://t.co/LYDpXslKNU #ASCOconnection
2022-12-29 10:20:01
Lamp
@ASCO This series illustrates how innovation is making significant strides in securing better access to the technologies and approaches that will have a positive impact on cancer control and health equity across the globe. https://t.co/VQn6GlCqew #ASCOconnection
2022-12-29 05:00:09
Lamp
@ASCO Miss a podcast episode or two this season? Catch up on some of the year’s most popular episodes from the Your Stories podcast—featuring doctors and patients who are conquering cancer. https://t.co/3LMZBl5ecw @ConquerCancerFd #ASCOconnection
2022-12-28 09:00:12
Lamp
@ASCO For #ASCODailyNews, Drs. @JuanAlderuccio and Alvaro J. Alencar of @umiamimedicine @SylvesterCancer examine CNS involvement in Burkitt lymphoma: https://t.co/gP0OJQhv1o #lymsm
2022-12-28 03:46:01
Lamp
@ASCO Supported by a Global Oncology Young Investigator Award from @ConquerCancerFd, Dr. Okello launched a retrospective study assessing the feasibility of two chemotherapies for treating patients with HIV-associated lymphoma. https://t.co/TZ9c16jktp #ASCOconnection
2022-12-27 08:00:02
Lamp
@ASCO 📚 See the top 3 books of 2022 according to our Oncology, Etc. podcast hosts Dr. Patrick Loehrer (@IU_Health) & Dr. Dave Johnson (@UTSWNews) plus a list of other books they & their podcast guests have discussed & recommended. https://t.co/seqsyY6Uiv #OncTwitter
2022-12-27 04:05:00
Lamp
@ASCO A new editorial from #ASCODailyNews aims to further unpack the role of positive psychologic well-being on outcomes in patients with #cancer: https://t.co/uQmDJpg4f5 @StephanieLeeMD @piaghanime #OncTwitter
2022-12-27 02:50:01
Lamp
@ASCO For #ASCODailyNews, Drs. Tiffany Foo, Amitesh Roy & @jrzalcberg assess the treatment landscape for advanced GISTs 20 years after imatinib’s approval: https://t.co/lHAQFDB5sj
2022-12-26 08:36:00
Lamp
@ASCO Congress passed year-end/2023 spending bill w several #ASCOadvocacy priorities: ✔️increased @NIH/@theNCI funding ✔️PAYGO delay ❌2% Medicare physician payment cut ✔️@US_FDA reforms ✔️telehealth expansion ❌prior auth reform https://t.co/QoaGlfWV0S
2022-12-23 00:00:00
Lamp
@ASCO Did you miss yesterday's #ASCOPlenarySeries session highlighting the utility of TIGIT inhibition in #NSCLC? Watch the recording here ➡️ https://t.co/IkFaW3lEhQ #lcsm #immunoonc @OncoAlert @MLJohnsonMD2 @marinagarassino @wolchokj @peters_solange https://t.co/39QuI3Zvpu
2022-12-22 00:00:00
Lamp
@ASCO Grateful to all of our coalition partners, the House Cancer Caucus, and our members that advocated on behalf of the #STARAct. This is a critical step to advancing pediatric cancer research. #ASCOAdvocacy https://t.co/bLnHKqMRg7
2022-12-22 00:00:00
Lamp
@ASCO Drs. @FernandoDiazMD1, @ReginaBarCar, and @AnaVManana share the stories of two Latino oncology fellows who discuss their motivations to impact the Hispanic/Latino population with cancer. https://t.co/AGRK4y7Y5K #ASCOconnection
2022-12-22 00:00:00
Lamp
@ASCO With the cost of #cancercare so high, it’s imperative to discuss how to overcome the overuse of inpatient chemo/IO with quality interventions. #ASCODailyNews has more: https://t.co/kafVAVEguG @nataliebergermd #financialtoxicity
2022-12-22 00:00:00
Lamp
@ASCO #ASCODailyNews covers the latest from @JCO_ASCO: Nivolumab & AVD show favorable long-term safety & efficacy in early-stage unfavorable cHL in final analysis of phase 2 NIVAHL trial: https://t.co/0om5DsU2HU
2022-12-22 00:00:00
Lamp
@ASCO Dr. Charles R. Thomas, a professor and chief of radiation oncology at @GeiselMed and @DartmouthCancer, shares insights from his career journey. https://t.co/RBh36P6q7H #ASCOconnection #radonc #OncTwitter
2022-12-21 00:00:00
Lamp
@ASCO For #ASCODailyNews, Dr. Yinghong Wang explores the complications posed by immune checkpoint inhibitor-induced colitis and the most effective tools for managing and mitigating this common adverse event: https://t.co/8IDG93YGZJ #GI23
2022-12-21 00:00:00
Lamp
@ASCO Don't miss the December #ASCOPlenarySeries TODAY @ 3 PM ET! This session will highlight the utility of TIGIT inhibition in #NSCLC. Presenter: @MLJohnsonMD2 Panelists: @marinagarassino @wolchokj @peters_solange Details ➡️ https://t.co/6Ya3qK0yhJ #lcsm #immunoonc @OncoAlert https://t.co/tIK4ZWvHvc
2022-12-20 00:00:00
Lamp
@ASCO For the past 3 years, we've been convening regional councils in Asia Pacific, Latin America, and sub-Saharan Africa. https://t.co/82l9myIANy #ASCOconnection #globaloncology
2022-12-20 00:00:00
Lamp
@ASCO We're proud to collaborate with @AmericanCancer to make the expert-approved information from both @CancerDotNet & https://t.co/83nGxA936n more easily available for readers, regardless of which website they turn to. https://t.co/bhSzMLHzdK
2022-12-20 00:00:00
Lamp
@ASCO We’ve issued a guideline update on therapy for stage IV #NSCLC with driver alterations: https://t.co/dZDbt6tFgH #lungcancer #lcsm https://t.co/Y1O0WgcWLC
2022-12-20 00:00:00
Lamp
@ASCO Just issued: Guideline update on therapy for stage IV #NSCLC without driver alterations ➡️ https://t.co/78YuyPkAKs #lungcancer #lcsm https://t.co/0OwyI9tIYY
2022-12-20 00:00:00
Lamp
@ASCO Breaking #ASCODailyNews coverage of this month's #ASCOPlenarySeries: Targeting PD-1 & TIGIT in #NSCLC is more efficacious than targeting PD-1 alone: https://t.co/F3B5kq4eCe @MLJohnsonMD2 @marinagarassino @wolchokj @peters_solange  #lcsm #immunoonc
2022-12-20 00:00:00
Lamp
@ASCO We've updated our living guidelines on therapy for stage IV #NSCLC with and without driver alterations based on newly available evidence in the field. #ASCODailyNews has more: https://t.co/VozFP3yLDM #lcsm @JCO_ASCO
2022-12-20 00:00:00
Lamp
@ASCO Now available: December #ASCOPlenarySeries abstract on the utility of TIGIT inhibition in #NSCLC Join us for the live presentation by @MLJohnsonMD2, expert discussion and Q&A tomorrow, 12/20, @ 3 PM ET View abstract ➡️ https://t.co/OeRqIuw6BO #lcsm #immunoonc @OncoAlert https://t.co/0BUFrvSgYr
2022-12-19 00:00:00
Lamp
@ASCO For #ASCODailyNews, @DrRoyHerbstYale and his @YaleCancer colleagues assess the work done thus far in deciphering TKI resistance in #NSCLC: https://t.co/b3NRVsIAik #lcsm
2022-12-19 00:00:00
Lamp
@ASCO @MLJohnsonMD2 @OncoAlert #ASCOPlenarySeries Panelists: @marinagarassino @wolchokj @peters_solange
2022-12-19 00:00:00
Lamp
@ASCO Volunteers from low- and middle-income countries bring essential perspective and experience to our global mission, shares @kasongomwaba. https://t.co/S1SD37vJUd #ASCOconnection #LMIC #globaloncology
2022-12-19 00:00:00
Lamp
@ASCO It’s down to the wire for Congress to avert the nearly 10% cut to Medicare reimbursement. 🗣️ Tell Congress in order to protect patients and providers they MUST stop the cuts by the end of the year‼️ https://t.co/5kpXJQlLK2 #ASCOAdvocacy #stopthefullcut #OncTwitter #MedTwitter
2022-12-18 00:00:00
Lamp
@ASCO Cuts to Medicare would be devastating for our nation’s seniors. Thank you @RepSusanWild & @RepMMM for leading a Congressional sign-on letter urging leadership to stop the cuts! Read the letter: https://t.co/tszjfjr7Uz #ASCOAdvocacy #stopthefullcut
2022-12-16 10:40:01
Lamp
@ASCO Our new guideline provides recommendations on immunotherapy and biomarker testing for patients with recurrent or metastatic head & neck cancers: https://t.co/Ssdl1imQSL @YilmazMDPhD @drlorenmell @JCO_ASCO #hncsm #immunoonc
2022-12-16 09:15:02
Lamp
@ASCO @cmpabon @AnaVManana @BernabeCarolina @DevikaDasMD @HemOncWomenDocs @AmandaNizamMD Thanks for your interest! If you have questions about participating in the #ASCOAdvocacySummit, please contact us at [email protected]
2022-12-16 08:30:59
Lamp
@ASCO Thank you @GOPDoctors for speaking up for patients and their providers by urging Congressional leadership to stop the drastic cuts to Medicare reimbursement prior to the end of the year. Read the letter ➡️ https://t.co/4DUp7Z3wU0 #ASCOAdvocacy #stopthefullcut
2022-12-16 08:30:01
Lamp
@ASCO ‼️ Congress has extended the deadline to reach a full funding agreement for FY23 by 1 more week. 🚨 Urge them to increase federal funding for #cancerresearch by passing a long-term funding bill for FY23 as quickly as possible! https://t.co/dkQGcmevsc #ASCOAdvocacy #OncTwitter
2022-12-16 08:00:01
Show more

Explain Login Issue or Your Query

We facilitates community members to help each other for login and availability-related problems of any website. So if you are facing an issue related to Asco Speaker Center Login or have any query regarding asco.org, please explain below:

Rating
28 Users Rated. Average Rating 3.89

Troubleshooting

Before login, must ensure following:
  • Keyboard CAPS lock is OFF
  • You are not using an old password
  • Your given email/login-name is valid
  • Its not a phishing website
  • Do not use VPN as some sites restrict VPN
  • The internet connection is active and login form is loading cache
  • If the site requires captcha, it must be valid. Regenerate if its not readable
  • Still not resolved? Visit FAQs page
Similar
Overview
Contributors
29
Reactions
135
Views
953
Updated
1 year ago
Contributors
Legendary
Denmark
Level 10
Populist
New York, United States
Level 9
Informed
Orange, California United States
Level 10
Organizer
Green Bay, WI
Level 9
Organizer
Sofia, Bulgaria
Level 10
Most Discussed
Recently Updated
Recently Joined
Promantas0123
India 4 hours ago
Prakash Kumar
India 4 hours ago
Forever Balanced Ther
India 4 hours ago
Daniel9876
Pakistan 5 hours ago
Kaytree Smith
Belgium 6 hours ago
Site Summary
LoginsLink is an online tool with a community forum that help to report website issues, get solutions and check latest status information of any website.
Total Users
78,138
Joined Today
11
Since
2020
Join Community